AstraZeneca’s cancer pipeline posts two wins and a loss
It has been a mixed few days for AstraZeneca’s oncology pipeline, as two drugs in its lung cancer portfolio have…
News
J&J’s Rybrevant linked to longest median OS in exon 20 EGFR NSCLC
Pressure intensifies on Novartis as bolt-on deal strategy faces major test
AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win
TenNor reports top-line Phase IIa results for rifaquizinone in PJI
Biohaven’s epilepsy drug hit with FDA clinical hold
First healthy volunteers dosed in Bionyra’s Phase I BYN-001 study
BioMarin paints picture of dwarfism drug’s wider efficacy on Phase III win
